Clinical trials
Terminated Phase 1/2 Lung Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celularity Incorporated | 1 |
| Mallinckrodt | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
| Rapa Therapeutics LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 4 |
| COVID-19 | 2 |
| Coronavirus Infections | 2 |
| Pneumonia | 2 |
| Acidosis, Respiratory | 1 |
| Acute Lung Injury | 1 |
| Albinism | 1 |
| Albinism, Oculocutaneous | 1 |
| Coronaviridae Infections | 1 |
| Cytokine Release Syndrome | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.